Research peptide · Neuropeptide research
Dihexa
Also known as PNB-0408 · N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide
A peptidomimetic built on a two-residue Tyr-Ile core, capped with a hexanoyl group at the N terminus and a 6-aminohexanoic amide at the C terminus. Molecular formula C27H44N4O5, average molecular weight 504.66 g/mol.
- Compound type
- Research peptide
- Research area
- Neuropeptide
- Formula
- C27H44N4O5
- Average mass
- 504.662 Da
- Monoisotopic mass
- 504.3312 Da
- Length
- 2 residues
- PubChem
- CID 129010512
What it is
Dihexa is a small synthetic peptidomimetic rather than an ordinary peptide. Its molecular formula is C27H44N4O5, its average molecular weight is 504.66 g/mol and its monoisotopic mass is 504.33. PubChem indexes it under CID 129010512 with the systematic name N-(1-oxohexyl)-L-tyrosyl-N-(6-amino-6-oxohexyl)-L-isoleucinamide, and it also appears under the development code PNB-0408.
Only two alpha-amino acids remain in the structure, tyrosine and isoleucine, and both ends are capped with aliphatic chains: a hexanoyl group on the tyrosine amine and a 6-aminohexanoic amide extending from the isoleucine carbonyl.
Discovery and origin
The compound comes out of a medicinal chemistry program on angiotensin IV analogs at Washington State University, reported in 2013. Earlier work in that program had placed the core structural information of the analog norleucine-1-angiotensin IV in its three N-terminal residues, Nle-Tyr-Ile. The 2013 paper modified that tripeptide at both termini, with the stated aim of increasing hydrophobicity and decreasing hydrogen bonding, and dihexa was the analog selected from that series 1.
Structure and chemistry
The molecule is more lipophilic than a peptide of comparable mass, which was the point of its design. Both charged termini are removed by the acyl and amide caps, leaving the phenolic hydroxyl of tyrosine as the only ionizable group of consequence, so the compound is effectively neutral in aqueous buffer and poorly soluble in it.
The tyrosine ring provides ultraviolet absorbance near 275 nm, convenient for chromatographic detection. There is no cysteine and no disulfide chemistry, and the two amide bonds and the terminal primary amide are the features most relevant to chemical stability.
How it is studied in the laboratory
The primary literature is rodent work from the originating group. The 2013 characterization paper assessed metabolic stability of the analog series in vitro and used standard rodent assays, including the Morris water maze in a scopolamine model and in aged rats, together with hippocampal synaptogenesis readouts 1. Two reviews place the compound in the wider angiotensin IV analog literature and summarize the rodent experimental work on that family 23. The research area is neuropeptide receptor pharmacology in rodent models, and no independent replication of the original rodent findings by a group outside the originating program was located.
Analytical notes
Identity is confirmed by liquid chromatography coupled to mass spectrometry in positive ion mode, where the expected singly protonated ion falls near m/z 505.34 on the average mass of 504.66, and a monoisotopic calculation on 504.33 gives essentially the same nominal value.
Purity is assessed by reversed-phase HPLC with ultraviolet detection on the tyrosine chromophore. The molecule is strongly retained on C18 and needs a high organic content to elute, which separates it from polar impurities. The peaks worth resolving are the partially capped synthetic intermediates and the free acid from hydrolysis of the terminal amide.
Storage and handling in the laboratory
As supplied, the material is a lyophilized powder, stored at -20 degrees Celsius, sealed and protected from light and moisture. Aqueous solubility is low, so stock solutions are usually prepared in an organic solvent and the point of precipitation on dilution into buffer is worth establishing first.
Open questions in the literature
The molecular target is unsettled. A 2014 paper that attributed the activity of this analog series to the hepatocyte growth factor and c-Met system was retracted in 2025, following an expression of concern in 2021, and cannot be used to support a mechanism 4. No binding study from an independent group has replaced it.
Identity check
A mass-spectrometry result for Dihexa should show peaks near these values. A result more than about one unit away is worth a question to the testing lab. Salt forms such as acetate or TFA do not move these peaks, though they do mean less peptide in each milligram of powder.
| Ion | Expected m/z |
|---|---|
| [M+H]+ | 505.34 |
References
- McCoy AT, Benoist CC, Wright JW, Kawas LH, Bule-Ghogare JM, Zhu M, Appleyard SM, Wayman GA, Harding JW. Journal of Pharmacology and Experimental Therapeutics. 2013;344(1):141-154. doi:10.1124/jpet.112.199497. Source
- Wright JW, Kawas LH, Harding JW. Progress in Neurobiology. 2015;125:26-46. doi:10.1016/j.pneurobio.2014.11.004. Source
- Ho JK, Nation DA. Neuroscience and Biobehavioral Reviews. 2018;92:209-225. doi:10.1016/j.neubiorev.2018.05.005. Source
- Benoist CC, Kawas LH, Zhu M, et al. Journal of Pharmacology and Experimental Therapeutics. 2014;351(2):390-402. RETRACTED; retraction 2025;392(4):103567. doi:10.1124/jpet.114.218735. Source
For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any disease.
